Search bioRxivSearch

bioRxiv · 10.1101/2020.09.03.282376

Effect of polyethylene glycol on growth of Escherichia coli DH5α and Bacillus subtilis NRS-762

Abstract

Polyethylene glycol is commonly used in fermentation as an anti-foam for preventing the rise of foam to the top plate of the bioreactor, which increases contamination risk. However, its potential toxicity to growth of various microorganisms is not well understood at the species and strain level. Hence, the objective of this study was to understand the impact of different concentrations of polyethylene glycol at the 1, 5 and 10 g/L level on the aerobic growth of Escherichia coli DH5 and Bacillus subtilis NRS-762 in LB Lennox medium in shake flasks. Experiment results revealed that polyethylene glycol (PEG) (molecular weight [~]8000 Da), at all concentrations tested, did not affect biomass formation and metabolism in E. coli DH5 at 37 {degrees}C. This came about through the observation of similar maximal optical density obtained during growth of E. coli DH5 under differing concentrations of PEG. Furthermore, the anti-foam did not affect the pH profile. On the other hand, PEG did exhibit some toxicity towards the growth of B. subtilis NRS-762 in LB Lennox medium. Specifically, maximal optical density obtained decline with higher exposure to PEG in a concentration dependent manner, up to a threshold concentration of 5 g/L. For example, maximal optical density obtained in B. subtilis NRS-762 without addition of PEG was 4.4, but the value obtained with 1 g/L of the anti-foam decreased to 4.1 and a further 3.8 on exposure to 5 g/L and 10 g/L PEG. pH variation in culture broth, however, told a different story, where the profiles for exposure to PEG at all concentrations coincide with each other and was similar to the one without exposure to the anti-foam; thereby, suggesting that metabolic processes in B. subtilis NRS-762 were not significantly affected by exposure to PEG. Collectively, PEG anti-foam exerted species-specific toxicity effect on biomass formation, and possibly metabolism. The latter may not be sufficiently significant to affect the types of metabolites secreted by the bacterium, and thus, be detected by measurement of pH of culture broth. E. coli DH5 was better able to cope with PEG at all concentrations compared to B. subtilis NRS-762, which showed dose-dependent toxicity effect on biomass formation. HighlightsO_LIPolyethylene glycol (molecular weight [~] 8000 Da) did not affect aerobic growth of Escherichia coli DH5 at 37 {degrees}C in LB medium at all concentrations tested: 0, 1, 5, 10 g/L. C_LIO_LIGrowth curves of the bacterium at different concentrations of polyethylene glycol (PEG) coincided with each other. C_LIO_LISimilar pH profiles were also obtained for E. coli DH5 growth in LB medium with different PEG concentrations. C_LIO_LIHowever, PEG exerted toxicity effect on Bacillus subtilis NRS-762 during growth in LB medium at 30 {degrees}C, with reduction of biomass formation in a dose dependent manner. C_LIO_LISimilar to the case for E. coli DH5. pH profiles of B. subtilis NRS-762 coincided with each other irrespective of the concentrations of PEG used. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ng, W.. 2020-09-04. Effect of polyethylene glycol on growth of Escherichia coli DH5α and Bacillus subtilis NRS-762. https://doi.org/10.1101/2020.09.03.282376

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology